Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2023-09-14 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's 2023 second extraordinary general meeting of shareholders. It includes details about the meeting date, attendance, voting results on specific proposals, and legal witness statements confirming the validity of the meeting and resolutions. There is no detailed financial data or comprehensive report content, but rather a summary of voting outcomes and meeting procedures. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1669 characters), and it is not a report publication announcement or regulatory filing. Therefore, the appropriate classification is DVA with high confidence.
2023-09-14 Chinese
普莱柯2023年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2023 Second Extraordinary General Meeting of Shareholders" of 普莱柯生物工程股份有限公司. It contains detailed meeting instructions, agenda, and two main proposals for shareholder approval: (1) use of idle raised funds for cash management, and (2) the 2023 interim profit distribution plan. The document includes procedural details about voting, meeting organization, and legal compliance references. It is clearly a set of meeting materials prepared for a shareholder meeting, not a report or announcement of results. The content is consistent with materials shared during a shareholders' meeting, which fits the definition of AGM Information (AGM-R). The document length is about 4617 characters, which is sufficient for detailed meeting materials but not a full annual or interim report. Therefore, the classification is AGM Information (AGM-R) with high confidence.
2023-09-07 Chinese
普莱柯关于2023年半年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from 普莱柯生物工程股份有限公司 regarding the 2023 half-year profit distribution plan. It details the dividend per share, total dividend amount, and the approval process including board and supervisory committee meetings. The document does not contain full financial statements or comprehensive financial analysis but focuses on the dividend distribution plan and related corporate governance approvals. The document length is short (1597 characters) and it is clearly an announcement of a dividend distribution plan rather than a full financial report or earnings release. Therefore, it fits best under the category of Notice of Dividend Amount (DIV).
2023-08-29 Chinese
普莱柯2023年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2023 Half-Year Special Report on the Deposit and Actual Use of Raised Funds" by 普莱柯生物工程股份有限公司. It details the amount of funds raised through a non-public stock issuance, the actual use of these funds during the first half of 2023, the management and storage of these funds, and compliance with regulatory requirements. It includes detailed tables on fund usage, cash management, and investment projects related to the raised funds. The document is a comprehensive report on the use and management of capital raised by the company, specifically focusing on the half-year period of 2023. This matches the category of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is not an announcement of a report publication, nor is it a full annual or interim financial report. It is a detailed update on fundraising and capital usage, fitting the CAP category.
2023-08-29 Chinese
普莱柯关于召开2023年半年度业绩说明会的公告
Call Transcript Classification · 70% confidence The document is an announcement about a scheduled investor conference call (performance explanation meeting) for the 2023 half-year results. It references that the half-year report was already disclosed on August 30, 2023, and this meeting is to discuss and answer investor questions interactively online. The document does not contain actual financial statements or detailed financial data but rather provides logistics and participation details for the event. This matches the characteristics of a Call Transcript (CT) type document, as it is about a conference call or earnings call event. However, since the document is only an announcement of the upcoming call and not the transcript itself, it is not a CT. It is also not a report publication announcement (RPA) because it does not announce the release of a report but rather the meeting to discuss it. Given the content, the best fitting category is Call Transcript (CT) as it relates to an earnings explanation meeting, but since it is only an announcement of the meeting, the classification is borderline. However, the document is specifically about the performance explanation meeting (业绩说明会), which is a type of earnings call. Therefore, the classification is CT with moderate confidence.
2023-08-29 Chinese
普莱柯关于使用部分闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the use of part of its idle raised funds for cash management. It details the investment purpose, amount, decision-making process, risk control measures, and approvals by the board, supervisory committee, and independent directors. It also includes the opinion of the sponsoring institution. The document is a formal disclosure about financing activities related to the company's raised funds, specifically about cash management of idle funds. It is not a full financial report, audit report, or earnings release. It is not a report publication announcement since it contains substantive information about the financing activity itself. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2023-08-29 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.